{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:06:25Z","timestamp":1792101985831,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2033,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.fertnstert.2016.07.1121","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T03:31:02Z","timestamp":1471231862000},"page":"1510-1520.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis"],"prefix":"10.1016","volume":"106","author":[{"given":"Daria","family":"Lizneva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kirubakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Mykhalchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Suturina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Chernukha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.07.1121_bib1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib2","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib5","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jmedgenet-2011-100427","article-title":"Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts","volume":"49","author":"Goodarzi","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib10","doi-asserted-by":"crossref","first-page":"E1342","DOI":"10.1210\/jc.2011-3478","article-title":"Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry","volume":"97","author":"Welt","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib11","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.fertnstert.2010.09.032","article-title":"Polycystic ovary syndrome: an ancient disorder?","volume":"95","author":"Azziz","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib12","unstructured":"National Institutes of Health. Evidence-based methodology workshop on polycystic ovary syndrome, December 3-5, 2012. Executive summary. Available at: https:\/\/prevention.nih.gov\/docs\/programs\/pcos\/FinalReport.pdf. Accessed March 1, 2016."},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib13","doi-asserted-by":"crossref","first-page":"E1088","DOI":"10.1210\/jc.2013-1295","article-title":"Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome","volume":"98","author":"Ezeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib14","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mce.2013.01.001","article-title":"The polycystic ovary syndrome and recent human evolution","volume":"373","author":"Corbett","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib18","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3109\/09513590.2013.819082","article-title":"Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics","volume":"29","author":"Ates","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib22","first-page":"477","article-title":"Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population","volume":"37","author":"Baldani","year":"2013","journal-title":"Coll Antropol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib23","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/humrep\/del306","article-title":"Is the PCOS diagnosis solved by ESHRE\/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?","volume":"21","author":"Belosi","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AOG.0b013e31823f7135","article-title":"A 20-year follow-up of young women with polycystic ovary syndrome","volume":"119","author":"Carmina","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1757-2215-5-42","article-title":"Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome","volume":"5","author":"Cinar","year":"2012","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib26","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligoanovulation with polycystic ovaries but not overt hyperandrogenism","volume":"91","author":"Dewailly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-0031-1277136","article-title":"The different phenotypes of polycystic ovary syndrome: no advantages for identifying women with aggravated insulin resistance or impaired lipids","volume":"119","author":"Cupisti","year":"2011","journal-title":"Exp Clin Endocrinol Diabet"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.02.020","article-title":"Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations","volume":"101","author":"Ladron de Guevara","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","article-title":"Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS","volume":"67","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF03401335","article-title":"Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)","volume":"13","author":"Georgopoulos","year":"2014","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib31","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","article-title":"Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes","volume":"94","author":"Guastella","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib32","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.rbmo.2010.04.032","article-title":"Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria","volume":"21","author":"Guo","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.fertnstert.2006.11.149","article-title":"Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990","volume":"88","author":"Hsu","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib34","first-page":"2185","article-title":"Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations","volume":"123","author":"Ma","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib35","first-page":"763","article-title":"The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females","volume":"16","author":"Mehrabian","year":"2011","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib36","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/1933719111414205","article-title":"The frequency of metabolic syndrome is higher among PCOS Brazilian women with menstrual irregularity plus hyperandrogenism","volume":"18","author":"Melo","year":"2011","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib37","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.fertnstert.2012.08.015","article-title":"CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes","volume":"98","author":"Moro","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/09513590.2011.633658","article-title":"Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?","volume":"28","author":"Ozkaya","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/humrep\/der418","article-title":"Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study","volume":"27","author":"Panidis","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2013.05.019","article-title":"Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome","volume":"170","author":"Sahmay","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib41","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.fertnstert.2007.01.032","article-title":"Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria","volume":"88","author":"Shroff","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib42","first-page":"253","article-title":"The prevalence of phenotypic subgroups in Greek women with polycystic ovarian syndrome","volume":"40","author":"Vaggopoulos","year":"2013","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/humrep\/deq310","article-title":"Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic","volume":"26","author":"Wijeyaratne","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib44","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1447-0756.2010.01478.x","article-title":"Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria","volume":"37","author":"Yilmaz","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib45","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1471-0528.2009.02347.x","article-title":"Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population","volume":"116","author":"Zhang","year":"2009","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-10-153","article-title":"Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-10-96","article-title":"Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare","volume":"10","author":"Gabrielli","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib48","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/humrep\/det469","article-title":"The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone","volume":"29","author":"Lauritsen","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib49","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study","volume":"28","author":"Li","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000277640","article-title":"Prevalence of polycystic ovary syndrome and related disorders in Mexican women","volume":"69","author":"Moran","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1477-7827-12-89","article-title":"The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran","volume":"12","author":"Tehrani","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7827-9-39","article-title":"The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study","volume":"9","author":"Tehrani","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib53","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/aogs.12706","article-title":"Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes","volume":"94","author":"Aziz","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib54","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/aogs.12612","article-title":"Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome","volume":"94","author":"Huang","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib55","doi-asserted-by":"crossref","first-page":"e0142772","DOI":"10.1371\/journal.pone.0142772","article-title":"Are dieting and dietary inadequacy a second hit in the association with polycystic ovary syndrome severity?","volume":"10","author":"Huijgen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-4755-12-7","article-title":"A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria","volume":"12","author":"Jamil","year":"2015","journal-title":"Reprod Health"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib57","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/aogs.12545","article-title":"Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes","volume":"94","author":"Mumm","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib58","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/1933719115611751","article-title":"The role of anti-Mullerian hormone in the characterization of the different polycystic ovary syndrome phenotypes","volume":"23","author":"Romualdi","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib59","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.fertnstert.2015.02.024","article-title":"Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome","volume":"103","author":"Zhang","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2307\/3002000","article-title":"Limitations of the application of fourfold table analysis to hospital data","volume":"2","author":"Berkson","year":"1946","journal-title":"Biometrics"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0895-4356(95)00031-3","article-title":"Impact of referral bias on clinical and epidemiological studies of Alzheimer\u2019s disease","volume":"49","author":"Kokmen","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib62","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1210\/jc.2014-1302","article-title":"Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias","volume":"99","author":"Castagna","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib63","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0025-6196(12)64794-6","article-title":"Selection bias in the referral of patients and the natural history of surgical conditions","volume":"60","author":"Melton","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.fertnstert.2016.07.1121_bib64","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216626663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216626663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:53:03Z","timestamp":1768909983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216626663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0015028216626663"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.07.1121","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.07.1121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}